In a double-blind crossover trial of three days duration on each drug, trimebutine in a dose of 200 mg three times daily was significantly more effective than placebo in relieving the symptoms of mild to moderate degrees of spastic colon (p<0.001).
The only side-effect necessitating discontinuation of treatment was one case of vomiting.
Get full access to this article
View all access options for this article.
References
1.
MoctezumaM UriasCastroBLeonGGuerraI (1977) Trimebutine en al tratamiento del colon irritable. (Trimebutine in the treatment of irritable colon). Investigation Medica Internacional4, 71.
2.
ParisJDelmotteJ S (1971) A pharmaco-radiological study of trimebutine on the colon. Gazette Médicate Francaise78, Suppl. 30, 37.
3.
ReboaGBertoglioCTerrizziAParodiE (1977) L'azione della trimebutina sull'attivita‘ elettrica e manometrica del colon normale e patologico. (The action of trimebutine on the electrical and manometric activity of the normal and pathological colon). Rivista di Gastro-Enterologia28, (1).
